Lily Chao is an Endocrinology/Metabolic physician affiliated with University of Southern California. OpenAlex indexes 74 publications with 3,962 citations (h-index 27); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4650 W Sunset Blvd
Los Angeles, CA 900276062
Telephone
323-660-2450Registry record last updated 21 Jul 2022.
Clinical trials
- Implementation of Team Clinic for Type 2 Diabetes (TCT2)
Sponsor: Children's Hospital Los Angeles
- Designing Team Clinic for Youth With Type 2 Diabetes
Sponsor: Children's Hospital Los Angeles
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- SANOFI-AVENTIS U.S. LLCProgram year20253 payments
- Mannkind CorporationProgram year20252 payments
- Abbott LaboratoriesProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2008–2010 per NIH RePORTER. The latest:
- Regulation of Glucose Metabolism by Skeletal Muscle Nuclear Receptor 4A
University of California Los Angeles
FY2010$140,724K08DK081683 - Regulation of Glucose Metabolism by Skeletal Muscle Nuclear Receptor 4A
University of California Los Angeles
FY2009$140,724K08DK081683 - Regulation of Glucose Metabolism by Skeletal Muscle Nuclear Receptor 4A
University of California Los Angeles
FY2009$1,080K08DK081683
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- GLP-1 receptor agonists reduce body mass index and total daily insulin dose in youth with type 1 diabetes: a retrospective cohort study
Journal of Pediatric Endocrinology and Metabolism
2025 - Prolonged Pubertal Suppression due to Retained Histrelin Implant in Three Children with Central Precocious Puberty
Hormone Research in Paediatrics
2025 - Exploratory real-world experience with GLP-1 receptor agonists vs. metformin in youth with new-onset type 2 diabetes: a single-center retrospective study
Journal of Pediatric Endocrinology and Metabolism
2025 - Decline in case rates of youth onset type 2 diabetes in year three of the COVID-19 pandemic
Journal of Pediatric Endocrinology and Metabolism
2024
Similar KOLs
Other experts from the same institution or the same specialty.
David Liebeskind, MD
University of Southern California
Lon Schneider, MD
University of Southern California
Amytis Towfighi, MD
University of Southern California
Norah Terrault, MD
University of Southern California
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”